0.4155
price down icon4.28%   -0.0186
after-market Handel nachbörslich: .42 0.0045 +1.08%
loading

Finanzdaten der Intensity Therapeutics Inc-Aktie (INTS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
20.30%
2.705
3.394 3.203 3.57 5.069
Operating Income/Loss
20.30%
-2.705
-3.394 -3.203 -3.57 -5.069
Income/Loss From Continuing Operations Before Tax
24.20%
-2.537
-3.347 -3.181 -3.513 -4.971
Income/Loss From Continuing Operations After Tax
24.20%
-2.537
-3.347 -3.181 -3.513 -4.971
Net Income/Loss
24.20%
-2.537
-3.347 -3.181 -3.513 -4.971
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
24.35%
18.87
15.17 0.1646 13.80 13.71
Diluted Average Shares
24.35%
18.87
15.17 0.1646 13.80 13.71
Basic Earnings Per Share
40.91%
-0.13
-0.22 -0.22 -0.25 -0.36
Diluted Earnings Per Share
40.91%
-0.13
-0.22 -0.22 -0.25 -0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$106.87
price up icon 0.90%
$34.26
price up icon 1.87%
$118.64
price up icon 10.48%
$99.85
price up icon 1.01%
biotechnology ONC
$337.89
price up icon 5.47%
$175.97
price up icon 3.35%
Kapitalisierung:     |  Volumen (24h):